Piperlongumine and immune cytokine TRAIL synergize to promote tumor death

Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer

(2014) Huiyuan Wang et al.   MOLECULAR PHARMACEUTICS

TRAIL-coated leukocytes that kill cancer cells in the circulation

(2014) M. J. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Enhanced localization of anticancer drug in tumor tissue using polyethylenimine-conjugated cationic liposomes

(2014) Hee Han et al.   Nanoscale Research Letters

Human fucosyltransferase 6 enables prostate cancer metastasis to bone

(2013) J Li et al.   BRITISH JOURNAL OF CANCER

Ulinastatin Exerts Synergistic Effects with Taxotere and Inhibits Invasion and Metastasis of Breast Cancer by Blocking Angiogenesis and the Epithelial–Mesenchymal Transition

(2013) Feng Gao et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Piperlongumine induces autophagy by targeting p38 signaling

(2013) Y Wang et al.   Cell Death & Disease

Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways

(2013) Jing Tang et al.   PLoS Computational Biology

Emerging targeted therapies in triple-negative breast cancer

(2012) J. Crown et al.   ANNALS OF ONCOLOGY

Understanding the biology of triple-negative breast cancer

(2012) C. Criscitiello et al.   ANNALS OF ONCOLOGY

Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy

(2012) J. S. Logue et al.   GENES & DEVELOPMENT

Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells

(2012) Huan Xie et al.   International Journal of Nanomedicine

On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics

(2012) L Y Dimberg et al.   ONCOGENE

The proliferation rate paradox in antimitotic chemotherapy

(2011) Timothy J. Mitchison   MOLECULAR BIOLOGY OF THE CELL

Selective killing of cancer cells by a small molecule targeting the stress response to ROS

(2011) Lakshmi Raj et al.   NATURE

Other Options in the Treatment of Advanced Breast Cancer

(2011) Melody A. Cobleigh   SEMINARS IN ONCOLOGY

Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy

(2010) N. Harbeck et al.   ANNALS OF ONCOLOGY

Improved Antitumor Activity and Tumor Targeting of NH2-Terminal-Specific PEGylated Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

(2010) S. Y. Chae et al.   MOLECULAR CANCER THERAPEUTICS

Cardiovascular Complications of Cancer Therapy

(2009) Edward T.H. Yeh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

(2009) Dunyaporn Trachootham et al.   NATURE REVIEWS DRUG DISCOVERY

The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway

(2008) S Wang   ONCOGENE